Zoster Vaccines; Risk of Guillain-Barré syndrome (GBS) following recombinant zoster vaccine(RZV); RZV risk-benefit analysis; Work group interpretation; Introduction of the Evidence to Recommendations Framework for use of RZV in immunocompromised adults.
Influenza Vaccines; Influenza surveillance update; Workgroup considerations

This video can also be viewed at
[ Ссылка ]

свернуть